鈴木栄治

最終更新日時: 2019/06/28 08:11:08

氏名(漢字／フリガナ／アルファベット表記)

鈴木栄治／スズキエイジ／Suzuki, Eizi

所属部署・職名(部局／所属／講座等／職名)

医学研究科／医学専攻外科学講座乳腺外科学／准教授

学部兼担

部局	所属	講座等	職名
医学部

学内兼務

部局	所属	講座等	職名
医学研究科	医学研究科	医学専攻

連絡先住所

種別	住所(日本語)	住所(英語)
職場	京都市左京区聖護院川原町54	54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan

連絡先電話番号

種別	番号
職場	075-751-3660

所属学会(国内)

学会名(日本語)	学会名(英語)
日本外科学会
日本乳癌学会
日本乳房オンコプラスティックサージェリー学会
日本癌治療学会

所属学会(海外)

学会名(英語)	国名
American Association for Cancer Research
American Society of Clinical Oncology
American Society of Breast Surgeons

取得学位

学位名(日本語)	学位名(英語)	大学(日本語)	大学(英語)	取得区分
博士（医学）		岡山大学

researchmap URL

https://researchmap.jp/7000009073

研究テーマ

(日本語)
腫瘍微小環境における免疫細胞の役割
(英語)
A role of immune cells in tumor microenvironment

研究分野（キーワード）

キーワード(日本語)	キーワード(英語)
腫瘍免疫	Tumor Immunity

論文

著者	著者(日本語)	著者(英語)	タイトル	タイトル(日本語)	タイトル(英語)	書誌情報等	書誌情報等(日本語)	書誌情報等(英語)	出版年月	査読の有無	掲載種別	公開
Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Szilagyi K, Schornagel K, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, Van Der Werff Ten Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK	Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Szilagyi K, Schornagel K, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, Van Der Werff Ten Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK	Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Szilagyi K, Schornagel K, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, Van Der Werff Ten Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK	Neutrophils kill antibody-opsonized cancer cells by trogoptosis	Neutrophils kill antibody-opsonized cancer cells by trogoptosis	Neutrophils kill antibody-opsonized cancer cells by trogoptosis	Cell Rep	Cell Rep	Cell Rep	2018	有		公開
Mackenzie L, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D’Este C, Yoshimura M, Toi M	Mackenzie L, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D’Este C, Yoshimura M, Toi M	Mackenzie L, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D’Este C, Yoshimura M, Toi M	Agreement between patients’ and radiation oncologists’ cancer diagnosis and prognosis perceptions: A cross sectional study in Japan	Agreement between patients’ and radiation oncologists’ cancer diagnosis and prognosis perceptions: A cross sectional study in Japan	Agreement between patients’ and radiation oncologists’ cancer diagnosis and prognosis perceptions: A cross sectional study in Japan	PLoS One	PLoS One	PLoS One	2018	有		公開
Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M	Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M	Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M	Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence	Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence	Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence	Breast Cancer	Breast Cancer	Breast Cancer	2018	有		公開
Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R	Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R	Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R	A cross sectional study of agreement between the Hospital Anxiety and Depression Scale, patient- and radiation oncologist-reported single-item assessment of depression and anxiety	A cross sectional study of agreement between the Hospital Anxiety and Depression Scale, patient- and radiation oncologist-reported single-item assessment of depression and anxiety	A cross sectional study of agreement between the Hospital Anxiety and Depression Scale, patient- and radiation oncologist-reported single-item assessment of depression and anxiety	Psychooncology	Psychooncology	Psychooncology	2018	有		公開
Sugie T, Suzuki E, Yamauchi A, Yamagami K,  Masuda N, Gondo N, Sumi E, Ikeda T, Tada H, Uozumi R, Kanao S, Tanaka T, Hamazaki Y, Minato N, Toi M	Sugie T, Suzuki E, Yamauchi A, Yamagami K,  Masuda N, Gondo N, Sumi E, Ikeda T, Tada H, Uozumi R, Kanao S, Tanaka T, Hamazaki Y, Minato N, Toi M	Sugie T, Suzuki E, Yamauchi A, Yamagami K,  Masuda N, Gondo N, Sumi E, Ikeda T, Tada H, Uozumi R, Kanao S, Tanaka T, Hamazaki Y, Minato N, Toi M	Combined effects of neoadjuvant letrozole and zoledronic acid on gdT cells in postmenopausal women with early-stage breast cancer	Combined effects of neoadjuvant letrozole and zoledronic acid on gdT cells in postmenopausal women with early-stage breast cancer	Combined effects of neoadjuvant letrozole and zoledronic acid on gdT cells in postmenopausal women with early-stage breast cancer	The Breast	The Breast	The Breast	2018	有		公開
Kawaguchi K, Suzuki E, Nishie M, Kii I, Kataoka TR, Hirata M, Inoue M, Pu F, Iwaisako K, Tsuda M, Yamaguchi A, Haga H, Hagiwara M, Toi M	Kawaguchi K, Suzuki E, Nishie M, Kii I, Kataoka TR, Hirata M, Inoue M, Pu F, Iwaisako K, Tsuda M, Yamaguchi A, Haga H, Hagiwara M, Toi M	Kawaguchi K, Suzuki E, Nishie M, Kii I, Kataoka TR, Hirata M, Inoue M, Pu F, Iwaisako K, Tsuda M, Yamaguchi A, Haga H, Hagiwara M, Toi M	Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity	Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity	Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity	Cancer Immunol Immunother	Cancer Immunol Immunother	Cancer Immunol Immunother	2017	有		公開
Hirata K, Yoshimura M, Inoue M, Yamauchi C, Orura M, Toi M, Suzuki E, Takeuchi M, Takada M and Hiraoka M	Hirata K, Yoshimura M, Inoue M, Yamauchi C, Orura M, Toi M, Suzuki E, Takeuchi M, Takada M and Hiraoka M	Hirata K, Yoshimura M, Inoue M, Yamauchi C, Orura M, Toi M, Suzuki E, Takeuchi M, Takada M and Hiraoka M	Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation	Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation	Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation	Journal of Radiation Research	Journal of Radiation Research	Journal of Radiation Research	2016	有		公開
Kawaguchi K, Suzuki E, Yamaguchi A, Yamamoto M, Morita S, Toi M	Kawaguchi K, Suzuki E, Yamaguchi A, Yamamoto M, Morita S, Toi M	Kawaguchi K, Suzuki E, Yamaguchi A, Yamamoto M, Morita S, Toi M	Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer	Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer	Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer	Breast Cancer	Breast Cancer	Breast Cancer	2016	有		公開
Kawaguchi-Sakita N, Kaneshiro-Nakagawa K, Kawashima M, Sugimoto M, Tokiwa M, Suzuki E, Kajihara S, Fujita Y, Iwamoto S, Tanaka K, Toi M	Kawaguchi-Sakita N, Kaneshiro-Nakagawa K, Kawashima M, Sugimoto M, Tokiwa M, Suzuki E, Kajihara S, Fujita Y, Iwamoto S, Tanaka K, Toi M	Kawaguchi-Sakita N, Kaneshiro-Nakagawa K, Kawashima M, Sugimoto M, Tokiwa M, Suzuki E, Kajihara S, Fujita Y, Iwamoto S, Tanaka K, Toi M	Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls	Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls	Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls	Biochem Biophys Res Commun	Biochem Biophys Res Commun	Biochem Biophys Res Commun	2015	有		公開
Suzuki E, Kataoka T, Hirata M, Kawaguchi K, Nishie M, Haga H and Toi M	Suzuki E, Kataoka T, Hirata M, Kawaguchi K, Nishie M, Haga H and Toi M	Suzuki E, Kataoka T, Hirata M, Kawaguchi K, Nishie M, Haga H and Toi M	Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients	Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients	Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients	BMC Cancer	BMC Cancer	BMC Cancer	2015	有		公開
Suzuki E, Mackenzie L, Sanson-Fisher R, Carey M, D'Este C, Asada H, Toi M	Suzuki E, Mackenzie L, Sanson-Fisher R, Carey M, D'Este C, Asada H, Toi M	Suzuki E, Mackenzie L, Sanson-Fisher R, Carey M, D'Este C, Asada H, Toi M	Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan	Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan	Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan	Int J Behav Med	Int J Behav Med	Int J Behav Med	2015	有		公開
Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H	Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H	Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H	The killer cell Ig-like receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion	The killer cell Ig-like receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion	The killer cell Ig-like receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion	Cancer Immunol Res	Cancer Immunol Res	Cancer Immunol Res	2015	有		公開
Sumi E, Sugie T, Yoshimura K, Tada H, Ikeda T, Suzuki E, Tanaka Y, Teramukai S, Shimizu A, Toi M, Minato N	Sumi E, Sugie T, Yoshimura K, Tada H, Ikeda T, Suzuki E, Tanaka Y, Teramukai S, Shimizu A, Toi M, Minato N	Sumi E, Sugie T, Yoshimura K, Tada H, Ikeda T, Suzuki E, Tanaka Y, Teramukai S, Shimizu A, Toi M, Minato N	Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol	Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol	Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol	J Transl Med	J Transl Med	J Transl Med	2014	有		公開
Quatromoni JG, Suzuki E, Okusanya O, Judy BF, Bhojnagarwala P, Venegas O, Eruslanov E, Predina JD, Albelda SM, Singhal S	Quatromoni JG, Suzuki E, Okusanya O, Judy BF, Bhojnagarwala P, Venegas O, Eruslanov E, Predina JD, Albelda SM, Singhal S	Quatromoni JG, Suzuki E, Okusanya O, Judy BF, Bhojnagarwala P, Venegas O, Eruslanov E, Predina JD, Albelda SM, Singhal S	The timing of TGF-beta inhibition affects the generation of antigen-specific CD8+ T Cells.	The timing of TGF-beta inhibition affects the generation of antigen-specific CD8+ T Cells.	The timing of TGF-beta inhibition affects the generation of antigen-specific CD8+ T Cells.	BMC Immunol	BMC Immunol	BMC Immunol	2013	有		公開
Honda M, Saji S, Horiguchi S, Suzuki E, Aruga T, Horiguchi K, Kitagawa D, Sekine S, Funata N, Toi M, Kuroi K	Honda M, Saji S, Horiguchi S, Suzuki E, Aruga T, Horiguchi K, Kitagawa D, Sekine S, Funata N, Toi M, Kuroi K	Honda M, Saji S, Horiguchi S, Suzuki E, Aruga T, Horiguchi K, Kitagawa D, Sekine S, Funata N, Toi M, Kuroi K	Clinicopathological analysis of ten patients with metaplastic squamous cell carcinoma of the breast.	Clinicopathological analysis of ten patients with metaplastic squamous cell carcinoma of the breast.	Clinicopathological analysis of ten patients with metaplastic squamous cell carcinoma of the breast.	Surg Today	Surg Today	Surg Today	2011	有		公開
Han HS, Reis IM, Zhao W, Kuroi K, Toi M, Suzuki E, Syme R, Chow L, Yip AY, Glück S	Han HS, Reis IM, Zhao W, Kuroi K, Toi M, Suzuki E, Syme R, Chow L, Yip AY, Glück S	Han HS, Reis IM, Zhao W, Kuroi K, Toi M, Suzuki E, Syme R, Chow L, Yip AY, Glück S	Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer.	Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer.	Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer.	Eur J Cancer	Eur J Cancer	Eur J Cancer	2011	有		公開
Fridlender ZG, Sun J, Singhal S, Kapoor V, Cheng G, Suzuki E, Albelda SM	Fridlender ZG, Sun J, Singhal S, Kapoor V, Cheng G, Suzuki E, Albelda SM	Fridlender ZG, Sun J, Singhal S, Kapoor V, Cheng G, Suzuki E, Albelda SM	Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms.	Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms.	Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms.	Mol Ther	Mol Ther	Mol Ther	2010	有		公開
Nakamura S, Yagata H, Ohno S, Yamaguchi H, Iwata H, Tsunoda N, Ito Y, Tokudome N, Toi M, Kuroi K, Suzuki E	Nakamura S, Yagata H, Ohno S, Yamaguchi H, Iwata H, Tsunoda N, Ito Y, Tokudome N, Toi M, Kuroi K, Suzuki E	Nakamura S, Yagata H, Ohno S, Yamaguchi H, Iwata H, Tsunoda N, Ito Y, Tokudome N, Toi M, Kuroi K, Suzuki E	Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer	Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer	Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer	Breast Cancer	Breast Cancer	Breast Cancer	2009	有		公開
Muta M, Yanagawa T, Sai Y, Saji S, Suzuki E, Aruga T, Kuroi K, Matsumoto G, Toi M, Nakashima E	Muta M, Yanagawa T, Sai Y, Saji S, Suzuki E, Aruga T, Kuroi K, Matsumoto G, Toi M, Nakashima E	Muta M, Yanagawa T, Sai Y, Saji S, Suzuki E, Aruga T, Kuroi K, Matsumoto G, Toi M, Nakashima E	Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells	Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells	Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells	Oncology	Oncology	Oncology	2009	有		公開
Aruga T, Suzuki E, Saji S, Horiguchi S, Horiguchi K, Sekine S, Kitagawa D, Funata N, Toi M, Sugihara K, Kuroi K	Aruga T, Suzuki E, Saji S, Horiguchi S, Horiguchi K, Sekine S, Kitagawa D, Funata N, Toi M, Sugihara K, Kuroi K	Aruga T, Suzuki E, Saji S, Horiguchi S, Horiguchi K, Sekine S, Kitagawa D, Funata N, Toi M, Sugihara K, Kuroi K	A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer	A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer	A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer	Oncol Rep	Oncol Rep	Oncol Rep	2009	有		公開
Suzuki E, Sun J, Kapoor V, Jassar AS, Albelda SM	Suzuki E, Sun J, Kapoor V, Jassar AS, Albelda SM	Suzuki E, Sun J, Kapoor V, Jassar AS, Albelda SM	Gemcitabine Has Significant Immunomodulatory Activity in Murine Tumor Models Independent of its Cytotoxic Effects	Gemcitabine Has Significant Immunomodulatory Activity in Murine Tumor Models Independent of its Cytotoxic Effects	Gemcitabine Has Significant Immunomodulatory Activity in Murine Tumor Models Independent of its Cytotoxic Effects	Cancer Biol Ther	Cancer Biol Ther	Cancer Biol Ther	2007	有		公開
Suzuki E and Toi M	Suzuki E and Toi M	Suzuki E and Toi M	mproving the efficacy of trastuzumab in breast cancer	mproving the efficacy of trastuzumab in breast cancer	mproving the efficacy of trastuzumab in breast cancer	Cancer Sci	Cancer Sci	Cancer Sci	2007	有		公開
Suzuki E, Niwa R, Saji S, Muta M, Hirose M, Iida S, Shiotsu Y, Satoh M, Shitara K, Kondo M, Toi M	Suzuki E, Niwa R, Saji S, Muta M, Hirose M, Iida S, Shiotsu Y, Satoh M, Shitara K, Kondo M, Toi M	Suzuki E, Niwa R, Saji S, Muta M, Hirose M, Iida S, Shiotsu Y, Satoh M, Shitara K, Kondo M, Toi M	A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients	A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients	A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients	Clin Cancer Res	Clin Cancer Res	Clin Cancer Res	2007	有		公開
Suzuki E, Kim S, Cheung HK, Corbley MJ, Zhang X, Sun L, Shan F, Singh J, Lee WC, Albelda SM, Ling LE	Suzuki E, Kim S, Cheung HK, Corbley MJ, Zhang X, Sun L, Shan F, Singh J, Lee WC, Albelda SM, Ling LE	Suzuki E, Kim S, Cheung HK, Corbley MJ, Zhang X, Sun L, Shan F, Singh J, Lee WC, Albelda SM, Ling LE	A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection	A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection	A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection	Cancer Res	Cancer Res	Cancer Res	2007	有		公開
Wilderman, M., Sun, J., Khan, M., Vachani, A., Suzuki E, Kinnery, P., Steman, D., Kaiser, L., Albelda, S.M	Wilderman, M., Sun, J., Khan, M., Vachani, A., Suzuki E, Kinnery, P., Steman, D., Kaiser, L., Albelda, S.M	Wilderman, M., Sun, J., Khan, M., Vachani, A., Suzuki E, Kinnery, P., Steman, D., Kaiser, L., Albelda, S.M	Intrapulmonary interferon-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of lung adenocarcinoma via a combination of direct toxicity, NK cell, and CD8 T-cell mediated effects	Intrapulmonary interferon-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of lung adenocarcinoma via a combination of direct toxicity, NK cell, and CD8 T-cell mediated effects	Intrapulmonary interferon-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of lung adenocarcinoma via a combination of direct toxicity, NK cell, and CD8 T-cell mediated effects	Cancer Research	Cancer Research	Cancer Research	2005	有		公開
Jassar, A., Suzuki E, Kapoor, V., Sun, J., Silverberg, M., Cheung, L., Burdick, M., Strieter, R., Ching, L-M., Kaiser, L.R., Albelda, S.M	Jassar, A., Suzuki E, Kapoor, V., Sun, J., Silverberg, M., Cheung, L., Burdick, M., Strieter, R., Ching, L-M., Kaiser, L.R., Albelda, S.M	Jassar, A., Suzuki E, Kapoor, V., Sun, J., Silverberg, M., Cheung, L., Burdick, M., Strieter, R., Ching, L-M., Kaiser, L.R., Albelda, S.M	Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma	Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma	Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma	Cancer Res	Cancer Res	Cancer Res	2005	有		公開
Suzuki E, Kapoor, V., Jassar, A., Kaiser, LR., Albelda, S.M	Suzuki E, Kapoor, V., Jassar, A., Kaiser, LR., Albelda, S.M	Suzuki E, Kapoor, V., Jassar, A., Kaiser, LR., Albelda, S.M	Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances anti-tumor immune activity	Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances anti-tumor immune activity	Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances anti-tumor immune activity	Clinical Cancer Research	Clinical Cancer Research	Clinical Cancer Research	2005	有		公開
Suzuki E, Kapoor V, Cheung HK, Ling LE, DeLong PA, Kaiser LR, Albelda SM	Suzuki E, Kapoor V, Cheung HK, Ling LE, DeLong PA, Kaiser LR, Albelda SM	Suzuki E, Kapoor V, Cheung HK, Ling LE, DeLong PA, Kaiser LR, Albelda SM	Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity	Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity	Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity	Clin Cancer Res	Clin Cancer Res	Clin Cancer Res	2004	有		公開
Suzuki E, Ota T, Tsukuda K, Okita A, Matsuoka K, Murakami M, Doihara H, Shimizu N	Suzuki E, Ota T, Tsukuda K, Okita A, Matsuoka K, Murakami M, Doihara H, Shimizu N	Suzuki E, Ota T, Tsukuda K, Okita A, Matsuoka K, Murakami M, Doihara H, Shimizu N	nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation	nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation	nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation	Int J Cancer	Int J Cancer	Int J Cancer	2004	有	学位論文(博士)	公開
Matsuoka K, Tsukuda K, Suda M, Kobayashi K, Ota T, Okita A, Watanabe K, Suzuki E, Murakami M, Doihara H, Shimizu N	Matsuoka K, Tsukuda K, Suda M, Kobayashi K, Ota T, Okita A, Watanabe K, Suzuki E, Murakami M, Doihara H, Shimizu N	Matsuoka K, Tsukuda K, Suda M, Kobayashi K, Ota T, Okita A, Watanabe K, Suzuki E, Murakami M, Doihara H, Shimizu N	The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil	The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil	The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil	Int J Oncol	Int J Oncol	Int J Oncol	2004	有		公開
<< < > >> 表示タイトル言語:

講演・口頭発表等

タイトル	タイトル(日本語)	タイトル(英語)	会議名	会議名(日本語)	会議名(英語)	開催年月日	公開
Potential role of lipid metabolic network related to anti-tumor immune response in breast cancer microenvironment	Potential role of lipid metabolic network related to anti-tumor immune response in breast cancer microenvironment	Potential role of lipid metabolic network related to anti-tumor immune response in breast cancer microenvironment	Cell Symposia	Cell Symposia	Cell Symposia	2018	公開
HER2陽性乳癌治療戦略における治療効果／耐性メカニズムの免疫学的意義[招待あり]	HER2陽性乳癌治療戦略における治療効果／耐性メカニズムの免疫学的意義 [招待あり]	HER2陽性乳癌治療戦略における治療効果／耐性メカニズムの免疫学的意義 [招待あり]	第26回日本乳癌学会学術総会ワークショップ	第26回日本乳癌学会学術総会ワークショップ		2018	公開
Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may contribute to the identification and the immunological classification of breast cancer patients by blood test	Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may contribute to the identification and the immunological classification of breast cancer patients by blood test	Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may contribute to the identification and the immunological classification of breast cancer patients by blood test	AACR	AACR	AACR	2017	公開
Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis	Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis	Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis	AACR	AACR	AACR	2016	公開
A role of trogocytosis of immune cells in breast tumor microenvironment[招待あり]	A role of trogocytosis of immune cells in breast tumor microenvironment [招待あり]	A role of trogocytosis of immune cells in breast tumor microenvironment [招待あり]	20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine	20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine	20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine	2015	公開
EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients	EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients	EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients	AACR	AACR	AACR	2015	公開
Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity	Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity	Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity	AACR	AACR	AACR	2014	公開
Upregulation of neuropilin-1 in human monocyte is induced by RANKL and may be associated with trastuzumab mediated antibody dependent cellular cytotoxicity in breast cancer cells	Upregulation of neuropilin-1 in human monocyte is induced by RANKL and may be associated with trastuzumab mediated antibody dependent cellular cytotoxicity in breast cancer cells	Upregulation of neuropilin-1 in human monocyte is induced by RANKL and may be associated with trastuzumab mediated antibody dependent cellular cytotoxicity in breast cancer cells	AACR	AACR	AACR	2013	公開
Acceptability of touch screen computer psychosocial survey to Japanese radiation therapy patients	Acceptability of touch screen computer psychosocial survey to Japanese radiation therapy patients	Acceptability of touch screen computer psychosocial survey to Japanese radiation therapy patients	COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology	COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology	COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology	2012	公開
bility of serum vascular endothelial growth factor in advanced or metastatic colorectal cancer patients to inhibit lymphokine activated killer cells	bility of serum vascular endothelial growth factor in advanced or metastatic colorectal cancer patients to inhibit lymphokine activated killer cells	bility of serum vascular endothelial growth factor in advanced or metastatic colorectal cancer patients to inhibit lymphokine activated killer cells	AACR	AACR	AACR	2011	公開
Serum vascular endothelial growth factor in advanced breast cancer patients might be a key role of inhibitory effect on lymphokine activated killer cells	Serum vascular endothelial growth factor in advanced breast cancer patients might be a key role of inhibitory effect on lymphokine activated killer cells	Serum vascular endothelial growth factor in advanced breast cancer patients might be a key role of inhibitory effect on lymphokine activated killer cells	AACR	AACR	AACR	2010	公開
Serum from breast cancer patients shows either augmentation or inhibition of lymphokine activated killer cells against human breast cancer cell line	Serum from breast cancer patients shows either augmentation or inhibition of lymphokine activated killer cells against human breast cancer cell line	Serum from breast cancer patients shows either augmentation or inhibition of lymphokine activated killer cells against human breast cancer cell line	AACR	AACR	AACR	2008	公開
<< < > >> 表示タイトル言語:

書籍等出版物

著者	著者(日本語)	著者(英語)	タイトル	タイトル(日本語)	タイトル(英語)	出版社	出版社(日本語)	出版社(英語)	出版年月	記述言語	担当区分	公開
Eiji Suzuki and Steven M. Albelda	Eiji Suzuki and Steven M. Albelda	Eiji Suzuki and Steven M. Albelda	Soluble Type II Transforming Growth Factor-b Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity	Soluble Type II Transforming Growth Factor-b Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity	Soluble Type II Transforming Growth Factor-b Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity							公開
タイトル言語:

外部資金：競争的資金・科学研究費補助金

種別	代表/分担	テーマ(日本語)	期間
基盤研究（Ｃ）	代表	乳癌に対するトラスツズマブ効果予測因子としてのニューロピリン1陽性免疫細胞の意義	2013〜2015
基盤研究（Ｃ）	代表	乳癌に対するトラスツズマブ効果予測因子としてのニューロピリン1陽性免疫細胞の意義（平成26年度分）	2014/04/01〜2015/03/31
基盤研究（Ｃ）	代表	乳癌に対するトラスツズマブ効果予測因子としてのニューロピリン1陽性免疫細胞の意義（平成27年度分）	2015/04/01〜2016/03/31
基盤研究(C)	代表	乳癌微小環境におけるマクロファージの脳転移特異的な役割の解明（平成29年度分）	2017/04/01〜2018/03/31
基盤研究(C)	代表	乳癌微小環境におけるマクロファージの脳転移特異的な役割の解明（平成30年度分）	2018/04/01〜2019/03/31

担当科目

講義名(日本語)	講義名(英語)	開講期	学部/研究科	年度
臨床外科疾病論Ⅱ	Clinical Overview of Surgery II	後期	医学部（人間健康科学科）	2014/04〜2015/03
臨床外科疾病論Ⅱ	Clinical Overview of Surgery II	後期	医学部（人間健康科学科）	2015/04〜2016/03
臨床外科疾病論Ⅱ	Clinical Overview of Surgery II	後期	医学部（人間健康科学科）	2016/04〜2017/03
臨床外科疾病論Ⅱ	Clinical Overview of Surgery II	後期	医学部（人間健康科学科）	2017/04〜2018/03
生殖科学II	Reproductive Science II	前期	医学研究科（人間健康科学系専攻）	2018/04〜2019/03
臨床疾病論G	Clinical Overview of Medicine G	前期後半	医学部（人間健康科学科）	2019/04〜2020/03
臨床疾病論G	Clinical Overview of Medicine G	前期後半	薬学部	2019/04〜2020/03

部局運営（役職等）

役職名	期間
リスクマネージャー会議委員	2011/04/01〜
病棟医長・看護師長会議委員	2013/02/01〜

鈴木 栄治

鈴木栄治